Avalo Therapeutics (AVTX) Gross Margin (2017 - 2024)
Avalo Therapeutics posted quarterly Gross Margin of 186.75% for Q3 2024, down 18209.0% year-on-year from N/an in Q4 2023, and down 234.64% on a QoQ basis from 138.7% in Q4 2023.
Avalo Therapeutics (AVTX) has 8 years of Gross Margin data on file, last reported at 186.75% in Q3 2024.
- For the quarter ending Q3 2024, Gross Margin fell 18209.0% year-over-year to 186.75%; the trailing twelve-month figure through Sep 2024 stood at 11.71% (down 1722.0% YoY), and the FY2023 full-year result was 33.26%, down 4771.0% from the prior year.
- Gross Margin for Q3 2024 stood at 186.75%, down from 138.7% in the prior quarter.
- Across five years, Gross Margin topped out at 138.7% in Q4 2023 and bottomed at 186.75% in Q3 2024.
- The 5-year median for Gross Margin is 32.74% (2021), against an average of 19.64%.
- The widest annual swing landed in 2022, when Gross Margin soared 12441 bps; it then plunged 18209 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 41.62% in 2020, then sank by 125 bps to 93.61% in 2021, then surged by 133 bps to 30.8% in 2022, then jumped by 350 bps to 138.7% in 2023, then tumbled by 235 bps to 186.75% in 2024.
- The last three Gross Margin figures came in at 186.75% (Q3 2024), 138.7% (Q4 2023), and 4.66% (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -186.75% |
| Dec 31, 2023 | 138.70% |
| Sep 30, 2023 | -4.66% |
| Jun 30, 2023 | -10.11% |
| Mar 31, 2023 | -16.00% |
| Dec 31, 2022 | 30.80% |
| Sep 30, 2022 | 96.47% |
| Jun 30, 2022 | -51.69% |
| Mar 31, 2022 | 38.62% |
| Dec 31, 2021 | -93.61% |
| Sep 30, 2021 | 32.74% |
| Jun 30, 2021 | 97.53% |
| Mar 31, 2021 | 83.72% |
| Dec 31, 2020 | -41.62% |
| Sep 30, 2020 | 93.07% |
| Jun 30, 2020 | 51.20% |
| Mar 31, 2020 | 75.42% |
| Dec 31, 2019 | 5.70% |
| Sep 30, 2019 | 93.99% |
| Jun 30, 2019 | -7.52% |
| Mar 31, 2019 | 84.62% |
| Dec 31, 2018 | 23.15% |
| Sep 30, 2018 | 23.65% |
| Jun 30, 2018 | 57.33% |
| Mar 31, 2018 | 99.64% |
| Dec 31, 2017 | 66.72% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | 100.00% |
| Mar 31, 2017 | 100.00% |